HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Virulence blockers as alternatives to antibiotics: type III secretion inhibitors against Gram-negative bacteria.

Abstract
In recent years mounting problems related to antibiotic-resistant bacteria have resulted in the prediction that we are entering the preantibiotic era. A way of preventing such a development would be to introduce novel antibacterial medicines with modes of action distinct from conventional antibiotics. Recent studies of bacterial virulence factors and toxins have resulted in increased understanding of the way in which pathogenic bacteria manipulate host cellular processes. This knowledge may now be used to develop novel antibacterial medicines that disarm pathogenic bacteria. The type III secretion system (T3SS) is known to be a potent virulence mechanism shared by a broad spectrum of pathogenic Gram-negative bacteria that interact with human, animal and plant hosts by injecting effector proteins into the cytosol of host cells. Diseases, such as bubonic plague, shigellosis, salmonellosis, typhoid fever, pulmonary infections, sexually transmitted chlamydia and diarrhoea largely depend on the bacterial proteins injected by the T3SS machinery. Recently a number of T3SS inhibitors have been identified using screening-based approaches. One class of inhibitors, the salicylidene acylhydrazides, has been subjected to chemical optimization and evaluation in several in vitro and ex vivo assays in multiple bacterial species including Yersinia spp., Chlamydia spp., Salmonella spp. and Pseudotuberculosis aeruginosa. Reports published up to date indicate that T3SS inhibitors have the potential to be developed into novel antibacterial therapeutics.
AuthorsP Keyser, M Elofsson, S Rosell, H Wolf-Watz
JournalJournal of internal medicine (J Intern Med) Vol. 264 Issue 1 Pg. 17-29 (Jul 2008) ISSN: 1365-2796 [Electronic] England
PMID18393958 (Publication Type: Journal Article)
Chemical References
  • Anti-Bacterial Agents
  • Bacterial Proteins
  • Virulence Factors
Topics
  • Anti-Bacterial Agents (therapeutic use)
  • Bacterial Proteins (antagonists & inhibitors)
  • Drug Resistance, Bacterial
  • Gram-Negative Bacteria (pathogenicity)
  • Gram-Negative Bacterial Infections (drug therapy)
  • Humans
  • Virulence (drug effects)
  • Virulence Factors (antagonists & inhibitors)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: